Seeking Alpha

ResMed (RMD +10.2%), a maker of equipment for treating respiratory disorders, is surging...

ResMed (RMD +10.2%), a maker of equipment for treating respiratory disorders, is surging following its FQ2 beat. Likely helping matters is an upgrade to Buy from Deutsche, which thinks the rebound seen in ResMed's U.S. equipment sales (Americas revenue rose 12% Y/Y) suggests the company can keep growing earnings at a double-digit annual clip. (transcript)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs